EUVIMEDEUVIMED entdecken
Open Access

Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model

Hadrian M Kinnear, Prianka H Hashim, Cynthia Dela Cruz, Faith L Chang, Gillian Rubenstein, Likitha Nimmagadda, Venkateswaran Ramamoorthi Elangovan, Andrea Jones, Margaret A Brunette, D Ford Hannum, Jun Z Li, Vasantha Padmanabhan und 2 weitere

Biology of Reproduction · 10.05.2023 · 108 (5) · 802-813

DOI: 10.1093/biolre/ioad019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Reproduction, online erschienen am 15.02.2023. Verfasst von Hadrian M Kinnear und 13 weiteren Autor:innen. Beteiligte Einrichtung: Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Ovary, Transgender Persons. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NICHD NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Some transmasculine individuals may be interested in pausing gender-affirming testosterone therapy and carrying a pregnancy. The ovarian impact of taking and pausing testosterone is not completely understood. The objective of this study was to utilize a mouse model mimicking transmasculine testosterone therapy to characterize the ovarian dynamics following testosterone cessation. We injected postpubertal 9–10-week-old female C57BL/6N mice once weekly with 0.9 mg of testosterone enanthate or a vehicle control for 6 weeks. All testosterone-treated mice stopped cycling and demonstrated persistent diestrus within 1 week of starting testosterone, while control mice cycled regularly. After 6 weeks of testosterone therapy, one group of testosterone-treated mice and age-matched vehicle-treated diestrus controls were sacrificed. Another group of testosterone-treated mice were maintained after stopping testosterone therapy and were sacrificed in diestrus four cycles after the resumption of cyclicity along with age-matched vehicle-treated controls. Ovarian histological analysis revealed stromal changes with clusters of large round cells in the post testosterone group as compared to both age-matched controls and mice at 6 weeks on testosterone. These clusters exhibited periodic acid–Schiff staining, which has been previously reported in multinucleated macrophages in aging mouse ovaries. Notably, many of these cells also demonstrated positive staining for macrophage markers CD68 and CD11b. Ovarian ribonucleic acid-sequencing found upregulation of immune pathways post testosterone as compared to age-matched controls and ovaries at 6 weeks on testosterone. Although functional significance remains unknown, further attention to the ovarian stroma may be relevant for transmasculine people interested in pausing testosterone to carry a pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OvaryTransgender PersonsPregnancyFemaleMiceAnimalsHumansMice, Inbred C57BLTestosteroneDisease Models, AnimalMice, Inbred StrainsMale

Stichwörter der Autor:innen

immunemacrophagemouseovarystromatestosteronetransgender

Substanzen

Testosterone

Autor:innen und Institutionen

  • Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA.
  • Medical Scientist Training Program, University of Michigan, Ann Arbor, MI, USA.
  • Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
  • Women's and Gender Studies Department, University of Michigan, Ann Arbor, MI, USA.
  • Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA.

Förderung

  • NCATS NIH HHS
  • NICHD NIH HHS
  • NIGMS NIH HHS
  • NIEHS NIH HHS
  • National Institutes of Health
  • American Society for Reproductive Medicine
  • Society for Reproductive Endocrinology and Infertility
  • University of Michigan Office of Research Funding

Zitieren

APA

Kinnear, H. M., Hashim, P. H., Dela Cruz, C., Chang, F. L., Rubenstein, G., Nimmagadda, L., Ramamoorthi Elangovan, V., Jones, A., Brunette, M. A., Hannum, D. F., Li, J. Z., Padmanabhan, V., Moravek, M. B., & Shikanov, A. (2023). Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model. Biology of Reproduction, 108(5), 802-813. https://doi.org/10.1093/biolre/ioad019

Vancouver

Kinnear HM, Hashim PH, Dela Cruz C, Chang FL, Rubenstein G, Nimmagadda L, et al. Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model. Biology of Reproduction. 2023;108(5):802-813. doi:10.1093/biolre/ioad019

BibTeX
@article{Kinnear2023,
  author = {Kinnear, Hadrian M and Hashim, Prianka H and Dela Cruz, Cynthia and Chang, Faith L and Rubenstein, Gillian and Nimmagadda, Likitha and Ramamoorthi Elangovan, Venkateswaran and Jones, Andrea and Brunette, Margaret A and Hannum, D Ford and Li, Jun Z and Padmanabhan, Vasantha and Moravek, Molly B and Shikanov, Ariella},
  title = {Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model},
  journal = {Biology of Reproduction},
  year = {2023},
  volume = {108},
  number = {5},
  pages = {802--813},
  doi = {10.1093/biolre/ioad019}
}
Kostenlos starten →